• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 肺炎合并多发性硬化症患者的肺部受累与残疾相关。

Lung involvement correlates with disability in MS patients with COVID-19 pneumonia.

机构信息

Emergency Department, Neurology Unit, Guglielmo da Saliceto Hospital, Via Giuseppe Taverna 39, 29121, Piacenza, Italy.

Section of Biostatistics, Department of Health Sciences, University of Genova, Genoa, Italy.

出版信息

Neurol Sci. 2022 Dec;43(12):6657-6659. doi: 10.1007/s10072-022-06333-z. Epub 2022 Aug 13.

DOI:10.1007/s10072-022-06333-z
PMID:35962215
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9374582/
Abstract

INTRODUCTION

The visual-well aerated lung (V-WAL) is a score for the visual quantification of the well aerated lung on CT scan in COVID-19 patients and its value at admission seems to predict future COVID-19 severity. The aim of the present study was to analyze the association between V-WAL and risk factors for severe COVID-19 evolution in people with multiple sclerosis.

MATERIALS AND METHODS

This is an observational retrospective study, including people with multiple sclerosis and concomitant COVID-19, who were investigated with a lung CT scan at Hospital admission. The association of V-WAL with age, sex, EDSS, comorbidities, recent steroid use, and treatment (anti-CD20 vs other) was assessed by a multivariate linear regression model.

RESULTS

In this observational retrospective study, the only factor that was significantly associated to a lower V-WAL at multivariable analysis was an increasing level of the EDSS (R = 0.41, p = 0.001), with an average decrease of 8% of V-WAL for each additional EDSS point.

DISCUSSION AND CONCLUSION

This analysis shows that a high EDSS level is the main factor associated to the severity of lung involvement in a group of people with multiple sclerosis who were hospitalized for Covid-19.

摘要

简介

视觉气腔肺(V-WAL)是一种用于评估 COVID-19 患者 CT 扫描上气腔肺的视觉量化评分,其入院时的分值似乎可以预测 COVID-19 的严重程度。本研究的目的是分析 V-WAL 与多发性硬化症患者发生严重 COVID-19 演变的危险因素之间的关联。

材料和方法

这是一项观察性回顾性研究,纳入了同时患有 COVID-19 和多发性硬化症的患者,他们在入院时接受了肺部 CT 扫描检查。通过多元线性回归模型评估 V-WAL 与年龄、性别、EDSS、合并症、近期类固醇使用以及治疗(抗 CD20 与其他)之间的相关性。

结果

在这项观察性回顾性研究中,多变量分析显示,唯一与 V-WAL 降低显著相关的因素是 EDSS 水平升高(R=0.41,p=0.001),EDSS 每增加 1 分,V-WAL 平均降低 8%。

讨论和结论

本分析表明,在因 COVID-19 住院的一组多发性硬化症患者中,EDSS 水平较高是与肺部受累严重程度相关的主要因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f2b/9374582/ed844bf07a44/10072_2022_6333_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f2b/9374582/ed844bf07a44/10072_2022_6333_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f2b/9374582/ed844bf07a44/10072_2022_6333_Fig1_HTML.jpg

相似文献

1
Lung involvement correlates with disability in MS patients with COVID-19 pneumonia.COVID-19 肺炎合并多发性硬化症患者的肺部受累与残疾相关。
Neurol Sci. 2022 Dec;43(12):6657-6659. doi: 10.1007/s10072-022-06333-z. Epub 2022 Aug 13.
2
Disease-modifying therapies, outcomes, risk factors and severity of COVID-19 in multiple sclerosis: A MENACTRIMS registry based study.多发性硬化症 COVID-19 的疾病修饰疗法、结局、风险因素和严重程度:一项 MENACTRIMS 登记研究。
Mult Scler Relat Disord. 2024 Oct;90:105790. doi: 10.1016/j.msard.2024.105790. Epub 2024 Jul 28.
3
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis.疾病修正疗法与多发性硬化症中 COVID-19 严重程度的关联。
Neurology. 2021 Nov 9;97(19):e1870-e1885. doi: 10.1212/WNL.0000000000012753. Epub 2021 Oct 5.
4
Chest X-ray versus chest computed tomography for outcome prediction in hospitalized patients with COVID-19.胸部 X 光与胸部计算机断层扫描对 COVID-19 住院患者预后的预测。
Radiol Med. 2022 Mar;127(3):305-308. doi: 10.1007/s11547-022-01456-x. Epub 2022 Jan 26.
5
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context.COVID-19 严重程度在多发性硬化症中的表现:将数据置于具体情境中。
Neurol Neuroimmunol Neuroinflamm. 2021 Nov 9;9(1). doi: 10.1212/NXI.0000000000001105. Print 2022 Jan.
6
Well-Aerated Lung and Mean Lung Density Quantified by CT at Discharge to Predict Pulmonary Diffusion Function 5 Months after COVID-19.通过CT量化出院时通气良好的肺和平均肺密度以预测COVID-19后5个月的肺扩散功能
Diagnostics (Basel). 2022 Nov 23;12(12):2921. doi: 10.3390/diagnostics12122921.
7
Visual and Quantitative Assessment of COVID-19 Pneumonia on Chest CT: The Relationship with Disease Severity and Clinical Findings.COVID-19 肺炎的胸部 CT 视觉和定量评估:与疾病严重程度和临床发现的关系。
Curr Med Imaging. 2021;17(9):1142-1150. doi: 10.2174/1573405617666210215142528.
8
B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran.B 细胞耗竭疗法可能会影响伊朗 COVID-19 疫情早期多发性硬化症患者急性呼吸道疾病的易感性。
Mult Scler Relat Disord. 2020 Aug;43:102195. doi: 10.1016/j.msard.2020.102195. Epub 2020 May 13.
9
A Soft Labeling Approach to Develop Automated Algorithms that Incorporate Uncertainty in Pulmonary Opacification on Chest CT using COVID-19 Pneumonia.一种利用 COVID-19 肺炎在胸部 CT 上对肺不透明度进行不确定性纳入的软标记方法来开发自动算法。
Acad Radiol. 2022 Jul;29(7):994-1003. doi: 10.1016/j.acra.2022.03.025. Epub 2022 Mar 30.
10
Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity.COVID-19 在多发性硬化症全球数据共享倡议中的更新结果:抗 CD20 和其他与 COVID-19 严重程度相关的风险因素。
Neurol Neuroimmunol Neuroinflamm. 2022 Aug 29;9(6). doi: 10.1212/NXI.0000000000200021. Print 2022 Nov.

引用本文的文献

1
Anti-RBD Antibody Levels and IFN-γ-Specific T Cell Response Are Associated with a More Rapid Swab Reversion in Patients with Multiple Sclerosis after the Booster Dose of COVID-19 Vaccination.抗受体结合域(RBD)抗体水平和干扰素-γ特异性T细胞反应与新冠病毒疫苗加强剂量接种后多发性硬化症患者更快的拭子转阴相关。
Vaccines (Basel). 2024 Aug 19;12(8):926. doi: 10.3390/vaccines12080926.

本文引用的文献

1
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France.DMTs 与多发性硬化症中 COVID-19 严重程度:来自意大利和法国的联合分析。
Ann Clin Transl Neurol. 2021 Aug;8(8):1738-1744. doi: 10.1002/acn3.51408. Epub 2021 Jul 7.
2
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.疾病修正疗法与多发性硬化症中 2019 年冠状病毒病严重程度。
Ann Neurol. 2021 Apr;89(4):780-789. doi: 10.1002/ana.26028. Epub 2021 Feb 9.
3
Stroke in COVID-19 patients-A case series from Italy.新冠病毒肺炎患者的中风——来自意大利的一组病例
Int J Stroke. 2020 Aug;15(6):701-702. doi: 10.1177/1747493020938294. Epub 2020 Jun 22.
4
Severe Covid-19.重症新型冠状病毒肺炎
N Engl J Med. 2020 Dec 17;383(25):2451-2460. doi: 10.1056/NEJMcp2009575. Epub 2020 May 15.
5
Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia.胸部 CT 显示充气良好的肺可预测 COVID-19 肺炎的不良结局。
Radiology. 2020 Aug;296(2):E86-E96. doi: 10.1148/radiol.2020201433. Epub 2020 Apr 17.